Stem, Inc. (NYSE:STEM – Get Free Report) has been assigned an average recommendation of “Reduce” from the five analysts that are covering the stock, Marketbeat reports. Two equities research analysts have rated the stock with a sell rating and three have assigned a hold rating to the company. The average twelve-month target price among brokerages that have updated their coverage on the stock in the last year is $12.3750.
Several equities research analysts have issued reports on STEM shares. UBS Group reaffirmed a “neutral” rating and set a $10.50 price target (down from $12.00) on shares of Stem in a research note on Monday, May 11th. Susquehanna dropped their price target on Stem from $21.00 to $10.00 and set a “neutral” rating for the company in a research note on Thursday, April 9th. Weiss Ratings lowered Stem from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Wednesday, April 29th. Wall Street Zen lowered Stem from a “sell” rating to a “strong sell” rating in a research note on Saturday, May 9th. Finally, Roth Mkm reaffirmed a “neutral” rating and set a $11.00 price target on shares of Stem in a research note on Thursday, May 7th.
View Our Latest Stock Analysis on Stem
Insider Buying and Selling at Stem
Institutional Inflows and Outflows
Hedge funds and other institutional investors have recently bought and sold shares of the business. IFP Advisors Inc grew its holdings in shares of Stem by 258.1% during the 3rd quarter. IFP Advisors Inc now owns 1,479 shares of the company’s stock worth $26,000 after acquiring an additional 1,066 shares during the period. International Assets Investment Management LLC purchased a new position in shares of Stem during the 4th quarter worth approximately $29,000. Skandinaviska Enskilda Banken AB publ purchased a new position in shares of Stem during the 3rd quarter worth approximately $55,000. Bridgeway Capital Management LLC purchased a new position in shares of Stem during the 2nd quarter worth approximately $97,000. Finally, Zweig DiMenna Associates LLC purchased a new position in shares of Stem during the 4th quarter worth approximately $125,000. Institutional investors own 61.63% of the company’s stock.
Stem Stock Performance
Shares of NYSE STEM opened at $7.71 on Friday. The stock has a market cap of $69.11 million, a PE ratio of -0.89 and a beta of 1.47. Stem has a fifty-two week low of $5.93 and a fifty-two week high of $32.23. The stock has a fifty day moving average of $9.70 and a 200-day moving average of $13.07.
Stem (NYSE:STEM – Get Free Report) last announced its quarterly earnings results on Wednesday, May 6th. The company reported ($2.22) earnings per share for the quarter, missing the consensus estimate of ($1.76) by ($0.46). The firm had revenue of $29.00 million during the quarter, compared to the consensus estimate of $34.61 million. On average, sell-side analysts predict that Stem will post -7.76 EPS for the current year.
About Stem
Stem, Inc is a technology company specializing in AI-driven energy storage and optimization solutions for commercial, industrial and utility customers. The company delivers integrated hardware and software systems that enable clients to manage energy consumption, reduce peak demand charges and provide ancillary services to the power grid. By combining battery storage hardware with advanced machine-learning algorithms, Stem helps organizations align energy usage with cost-saving opportunities while supporting grid reliability and renewable integration.
At the core of Stem’s offering is its Athena software platform, which uses real-time data and predictive analytics to forecast energy needs and automatically dispatch stored energy when it is most valuable.
Further Reading
- Five stocks we like better than Stem
- Samsara Just Answered The AI Question—Is Wall Street Ready To Listen?
- IREN’s 800MW Bet Flips the AI Power Switch
- CrowdStrike Earnings Beat Sparks Selloff—Buy the Dip?
- Tesla’s EV Rebound Leaves Rivian and Lucid Facing a Tougher Investor Test
Receive News & Ratings for Stem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stem and related companies with MarketBeat.com's FREE daily email newsletter.
